Law & Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Law & Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Guided Therapeutics, Inc.
Guided Therapeutics, Inc. and Konica Minolta Opto, Inc. to Jointly Develop Cancer Detection Products
June 6th, 2009
Guided Therapeutics, Inc. (GT) (Pink Sheets: GTHP) announced that it has entered into an agreement with Konica Minolta Opto, Inc. (KMOT) of Tokyo to co-develop non-invasive cancer detection products. The new development agreement follows two years of collaborative preparations to identify large market opportunities that would benefit from GT’s proprietary technology. The new products, for the detection of lung and esophageal cancer, are based on GT’s LightTouch™ non-invasive cervical cancer detection technology, which is undergoing the U.S. Food and Drug Administration’s premarket approval process. Lung cancer is the most prevalent cancer in the world and esophageal...
Source: Law & Health Weekly (2009-06-06)
|
